Heron Therapeutics, Inc.HRTXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 89 | 86↓2.6% | 108↑24.7% | 127↑18.0% | 144↑13.6% |
| Gross Profit | 52 | 40↓23.1% | 53↑30.9% | 62↑17.3% | 106↑70.6% |
| Operating Income | -228 | -218↑4.5% | -175↑19.8% | -111↑36.7% | -12↑89.6% |
| Net Income | -227 | -221↑2.9% | -182↑17.5% | -111↑39.3% | -14↑87.7% |
| EBITDA | -223 | -215↑3.3% | -177↑17.9% | -104↑41.2% | -5↑95.1% |
| EPS Diluted | -2.50 | -2.24↑10.4% | -1.67↑25.4% | -0.80↑52.1% | -0.09↑88.9% |